HN Summary
• UHN surgeons are curing a rare and potentially fatal lung condition, CTEPH, using one of the world’s most advanced surgical procedures — pulmonary thromboendarterectomy (PTE) — which removes chronic blood clots from even the smallest pulmonary vessels. UHN operates the largest and...
E-cigarettes, commonly known as vapes, contain nicotine and various chemicals, including some used for flavourings, which make them more attractive to young people. Despite measures to protect youth, such as age restrictions and flavour bans, all types of vaping products remain easily available online....
Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.